Advocacy intelligence hub — real-time data for patient organizations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Avastin
Genentech, Inc.
Gliadel
(polifeprosan 20 with carmustine)Orphan drugstandardGuilford Pharmaceuticals, Inc.
Alkylating Drug [EPC]
12.1 Mechanism of Action The activity of GLIADEL Wafer is due to release of cytotoxic concentrations of carmustine, a DNA and RNA alkylating agent, in...
Ira J Dunkel, MD
Children's Oncology Group
📍 NEW YORK, NY
Debra L Friedman
Children's Oncology Group
Sara M. Federico, MD, MD
St. Jude Children's Research Hospital
📍 MEMPHIS, TN
Elise F Nassif, MD
University of Texas MD Anderson Cancer Center LAO
📍 HOUSTON, TX
Danielle Novetsky Friedman, MD
Memorial Sloan Kettering Cancer Center
Huashen Yang
Sun Yat-sen University